US$ 28.89
glp 1 agonism GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal What is GLP-1 and Its
Description
10.1097/GME.0000000000000640 20

These medications affect gastric emptying and glucose metabolism , which may pose risks during anaesthesia

Harkavyi A, Whitton PS

These are tiny sample sizes by medical research standards

95% CI, 0.58-0.95)
